TRPM4 inhibition by meclofenamate suppresses Ca2+-dependent triggered arrhythmias.
Frone VandewieleAndy PironetGriet JacobsMiklos KecskésJörg W WegenerSara KerselaersLio HendrikxJoren VerelstKoenraad PhilippaertWouter OosterlinckAndrei SegalEvy Van Den BroeckSilvia PintoSilvia Giuliana PrioriStephan E LehnartBernd NiliusThomas VoetsRudi VennekensPublished in: European heart journal (2022)
The presented data establish that TRPM4 represents a novel target in the prevention and treatment of Ca2+-dependent triggered arrhythmias.